Skip to main content
Premium Trial:

Request an Annual Quote

Proteome Systems to Acquire Eukarion in Cash-and-Shares Deal

NEW YORK, Dec. 17 (GenomeWeb) - Proteome Systems of Sydney, Australia, will acquire privately held Eukarion of Bedford, Mass. in a cash-and-shares transaction expected to close in February, the companies said today.

 

The majority of the purchase is payable in 1.7 million Proteome Systems shares based on meeting milestones in clinical development, licensing revenues, and drug product sales, the company said in a statement.

 

Proteome Systems will acquire a suite of pre-clinical antioxidant drug candidates, and staff, which will move to Proteome Systems Boston facility, the company said.

The Scan

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.

Study Reveals Potential Sex-Specific Role for Noncoding RNA in Depression

A long, noncoding RNA called FEDORA appears to be a sex-specific regulator of major depressive disorder, affecting more women, researchers report in Science Advances.

New mRNA Vaccines Offer Hope for Fighting Malaria

A George Washington University-led team has developed mRNA vaccines for malaria that appear to provide protection in mice, as they report in NPJ Vaccines.

Unique Germline Variants Found Among Black Prostate Cancer Patients

Through an exome sequencing study appearing in JCO Precision Oncology, researchers have found unique pathogenic or likely pathogenic variants within a cohort of Black prostate cancer patients.